Meet Aevice Health! Founded in 2016, this Singapore-based startup develops wearable devices for remote management of chronic respiratory diseases.

And they just raised an undisclosed amount of early-stage funding!

Investor check. East Ventures led the round.

• They last raised $2.1M in a Pre-Series A round.

‍

🫁 A health crisis

In SEA, 48.5M people suffer from chronic respiratory diseases, and 4M die prematurely every year.

• With air pollution worsening by the day, Chronic Obstructive Pulmonary Disease (COPD) or diseases that limit airflow is expected to be the third leading cause of death by 2030.

Respiratory diseases require regular medical attention, and are expensive to deal with!

• More than $3K is spent on every Asthma patient in the US, yet 1300 deaths still occur daily. COPD, another leading respiratory disease, sees 72% underdiagnosed globally.

‍

📅 24/7/365

Monitoring your loved ones’ health has never been easier! With Aevice Health’s devices, you can do it 24/7.

• Plus, their devices are super convenient to use!

For adults — AeviceMD serves as a wearable stethoscope. Simply stick the circular device to your chest and monitor heart rate, respiratory rate, wheeze and cough detection in-real-time from your phone!

• Get alerts when it senses early signs of illness
• Share your data with a doctor with one click for a more customized treatment plan
• The device is Singapore Health and Science Authority (HSA) and FDA-approved

For kids — Airsone Junior is a coin-sized wearable (10g) that tracks respiratory and heart rate. Oh, and it also provides insights into sleep quality and overall well-being!

• All data is displayed on an easy-to-use app.
• Get push notifications when concerning vitals are observed.

‍

💼 They mean business

With the new $$$, Aevice is now closer to achieving its end goal for its devices to be as common as a thermometer!